Jing Li

Title: Innovations and Contributions of Inventor Jing Li

Introduction

Jing Li is a notable inventor based in Tianjin, China, recognized for his contributions to the fields of medical treatment and automotive safety. With a total of two patents to his name, he has made significant strides in developing innovative solutions that address critical issues.

Latest Patents

Jing Li's latest patents include a method of treating non-alcoholic steatohepatitis (NASH) using a long-acting mutant human fibroblast growth factor. This invention involves administering a specific long-acting mutant human fibroblast growth factor, mPEG-CH—NH-mFGF21, to individuals in need of treatment. The second patent focuses on a method and system for measuring the relationship between crash dummy chest compression and safety belt load. This method includes controlling a chest cover plate to maintain a preset position relative to the dummy and determining a target pulling force-displacement curve for safety assessments.

Career Highlights

Throughout his career, Jing Li has worked with prominent organizations such as the China Automotive Technology and Research Center Co., Ltd. and the Catarc Automotive Test Center (Tianjin) Co., Ltd. His experience in these institutions has allowed him to apply his innovative ideas in practical settings, contributing to advancements in automotive safety and medical treatments.

Collaborations

Jing Li has collaborated with several professionals in his field, including Hua Zhou and Zhixin Liu. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Jing Li's work exemplifies the spirit of innovation and dedication to improving health and safety through his inventions. His contributions continue to impact various industries, showcasing the importance of research and development in addressing contemporary challenges.